FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “ Vaccinex, Inc Surges After Announcing Two Mulit-Project Deals with Leading Pharmaceutical Companies ”
Vaccinex, Inc. (NASDAQ: VCNX) skyrocketed over 106% in premarket trading after the company announced the signing of multi-project deals with two undisclosed prominent pharmaceutical companies.
The collaborations will focus on using ActivMAb®, Vaccinex’s antibody discovery and novel viral display platform, for antibody discovery against complex antigens such as GPCRs and ion channels.
Vaccinex, Inc. is pioneering a differentiated approach to treating neurodegenerative disease through the inhibition of semaphorin 4D (SEMA4D), a key driver of neuroinflammation. The company’s lead drug candidate, pepinemab, blocks SEMA4D and has potential as a disease-modifying treatment for Huntington’s, Alzheimer’s and other neurodegenerative diseases. Beyond neurology, Vaccinex believes that, in combination with checkpoint inhibitors, pepinemab has potential to increase objective responses in oncology. The company additionally intends to leverage its proprietary drug discovery platform, ActivMAb ® , to create opportunities for future pipeline expansion and strategic collaborations.
For more information, please visit: Vaccinex, Inc.
About The Buzz: A Financial Buzz Show on daily news, covering the most up to date financial information. The Buzz intends to provide factual and relevant information for its audience. The Buzz is 100% original content, created by Financial Buzz Media. Located on Wall Street in the heart of New York City’s financial district, FinancialBuzz.com is a credible source for the world’s latest trending financial and economic news. A pioneer in the financially driven digital space, video production and integration of social media, FinancialBuzz.com creates 100% unique original content.
The post “The Buzz” Show: Vaccinex Inc. (NASDAQ: VCNX) Announces Deals with Leading Pharmaceutical Companies first appeared on Financial Buzz .
For further details see:
“The Buzz” Show: Vaccinex Inc. (NASDAQ: VCNX) Announces Deals with Leading Pharmaceutical Companies